Stockscreener 앱 받기
220.47
0.91%
-2.03
시간 외 거래:
219.40
-1.07
-0.49%
전일 마감가:
$222.50
열려 있는:
$222.51
하루 거래량:
984.90K
Relative Volume:
0.94
시가총액:
$32.12B
수익:
$5.40B
순이익/손실:
$1.49B
주가수익비율:
21.79
EPS:
10.1168
순현금흐름:
$1.78B
1주 성능:
-2.44%
1개월 성능:
-13.97%
6개월 성능:
-18.43%
1년 성능:
-0.97%
1일 변동 폭
$219.56
$222.51
1주일 범위
$219.40
$232.60
52주 변동 폭
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
명칭
Resmed Inc
전화
(858) 746-2400
주소
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Compare RMD vs ISRG, BDX, ALC, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
220.47 | 32.12B | 5.40B | 1.49B | 1.78B | 10.12 |
ISRG
Intuitive Surgical Inc
|
452.66 | 160.77B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.51 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
73.34 | 35.75B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
41.36 | 33.57B | 28.43B | 1.16B | 1.26B | 1.4457 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-09-18 | 개시 | Citigroup | Buy |
| 2025-09-02 | 업그레이드 | CLSA | Hold → Outperform |
| 2025-07-15 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 개시 | Morgan Stanley | Overweight |
| 2025-01-16 | 개시 | Goldman | Buy |
| 2025-01-10 | 개시 | Piper Sandler | Neutral |
| 2024-12-13 | 개시 | Stifel | Hold |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-09-18 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | 다운그레이드 | Needham | Buy → Hold |
| 2024-06-25 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-06-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | 업그레이드 | Needham | Hold → Buy |
| 2023-09-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 개시 | UBS | Buy |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-01-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-09-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-08-15 | 다운그레이드 | CLSA | Buy → Outperform |
| 2022-08-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-31 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-01-28 | 업그레이드 | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-01-13 | 업그레이드 | CLSA | Outperform → Buy |
| 2022-01-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-10-22 | 업그레이드 | CLSA | Underperform → Outperform |
| 2021-08-02 | 다운그레이드 | CLSA | Outperform → Sell |
| 2021-08-02 | 다운그레이드 | Needham | Buy → Hold |
| 2021-07-28 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 개시 | RBC Capital Mkts | Underperform |
| 2021-06-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-06-22 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-06-22 | 개시 | Robert W. Baird | Neutral |
| 2021-06-21 | 재확인 | Needham | Buy |
| 2021-06-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-09 | 업그레이드 | CLSA | Sell → Outperform |
| 2021-05-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-04-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-03-16 | 업그레이드 | Needham | Hold → Buy |
| 2020-11-02 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-30 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-10-27 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-01 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 개시 | CLSA | Underperform |
| 2020-01-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Perform |
| 2019-11-22 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | 업그레이드 | UBS | Neutral → Buy |
| 2019-07-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-05-06 | 업그레이드 | UBS | Neutral → Buy |
| 2019-04-18 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-01-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-01-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-10-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 개시 | Goldman | Buy |
모두보기
Resmed Inc 주식(RMD)의 최신 뉴스
Eagleford Energy and ResMed Compared - National Today
ResMed Inc. Stock: Navigating Sleep Apnea Market Leadership Amid Demographic Tailwinds and Digital I - ad-hoc-news.de
ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress - MSN
RBC Capital Maintains ResMed Inc.Depositary Receipt (RSMDF) Outperform Recommendation - MSN
ResMed stock price forecast: technical weakness persists as RMD struggles below key moving averages - Traders Union
Vanguard (RMD) disaggregates holdings; reports zero ownership in ResMed - Stock Titan
Regatta Capital Group LLC Invests $2.51 Million in ResMed Inc. - nationaltoday.com
Regatta Capital Group LLC Takes $2.51 Million Position in ResMed Inc. $RMD - MarketBeat
ResMed & Netwealth: A Fresh Look at Valuation Trends - Kalkine Media
Dakota Wealth Management Has $8.18 Million Holdings in ResMed Inc. $RMD - MarketBeat
Assenagon Asset Management S.A. Has $19.43 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock outperforms market despite losses on the day - MarketWatch
ResMed Inc. stock: Leader in sleep and respiratory care with strong North American market presence - AD HOC NEWS
Unpacking Q4 Earnings: ResMed (NYSE:RMD) In The Context Of Other Patient Monitoring Stocks - Yahoo Finance
Is ResMed stock underperforming the Nasdaq? - MSN
ResMed Inc. (RMD.AX) Alternative Data AnalyticsSocial & Digital Signals - Meyka
ResMed Inc stock faces pressure amid slowing sleep apnea device demand and insurance reimbursement h - AD HOC NEWS
ResMed Share Price Insights: Is RMD Worth Watching in 2026? - Kalkine Media
ResMed Inc. stock faces pressure amid weak performance and uncertain outlook in sleep apnea market - AD HOC NEWS
Research Alert: CFRA Lowers Rating On Shares Of Resmed Inc. To Hold From Buy - Moomoo
ResMed (RMD) Downgraded by Baird, Price Target Lowered to $275 | - GuruFocus
Nordea Investment Management Boosts ResMed Stake by 37% - National Today
Nordea Investment Management AB Purchases 294,124 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock advances amid strong Q2 earnings and digital health push, drawing DACH investor in - AD HOC NEWS
After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD) - Yahoo Finance
ResMed Inc (NYSE:RMD): A Quality Dividend Stock Built on Strong Fundamentals - ChartMill
ResMed Inc. $RMD Shares Acquired by Mirabella Financial Services LLP - MarketBeat
ResMed Inc Stock (ISIN: AU000000RMD6) Faces Pressure Amid Recent Declines: What European Investors N - AD HOC NEWS
Danske Bank A S Buys New Stake in ResMed Inc. $RMD - MarketBeat
ResMed (RMD) Is Down 5.1% After Market Value Slides Despite Solid Fundamentals Has The Bull Case Changed? - sahmcapital.com
ResMed Inc. stock falls Wednesday, underperforms market - MarketWatch
Captrust Financial Advisors Increases Stake in ResMed Inc. - National Today
Captrust Financial Advisors Buys 27,565 Shares of ResMed Inc. $RMD - MarketBeat
Achmea Investment Management B.V. Decreases Stake in ResMed Inc. $RMD - MarketBeat
With global populations ageing, are ResMed shares a good buy today? - The Motley Fool Australia
Why Cochlear and ResMed shares could be strong buys - The Motley Fool Australia
ResMed Inc. stock rises Tuesday, outperforms market - MarketWatch
ResMed Stock In Shambles: Down 6.7% With 5-Day Losing Streak - Trefis
Is Resmed Shares a Smart Addition to Your Investment Portfolio at This Time? - Bitget
ResMed (RMD) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Is Resmed Stock the Right Pick for Your Portfolio Now? - TradingView
After Plunging 8.7% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD) - Yahoo Finance
Mirabella Financial Services LLP Purchases 5,562 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Stock Plummets 8.8% With 5-Day Losing Streak - Trefis
Short Interest in ResMed Rises 17.2% - National Today
ResMed Stock Slides -8.8% With A 5-Day Losing Spree - Trefis
Short Interest in ResMed Inc. (NYSE:RMD) Grows By 17.2% - MarketBeat
California Public Employees Retirement System Has $78.58 Million Position in ResMed Inc. $RMD - MarketBeat
ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating (NYSE:RMD) - Seeking Alpha
ResMed, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Stifel reiterates Hold on ResMed stock, keeps $265 price target By Investing.com - Investing.com South Africa
Resmed Inc (RMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.01%
자본화:
|
볼륨(24시간):